Most Read Articles
15 Feb 2020
A new noninvasive risk score―incorporating factors such as waist circumference, age, sex, and histories of hyperglycaemia and diabetes in the family― reliably identifies those at high dysglycaemia risk, reports a new Saudi Arabia study.
Yesterday
There appears to be no association between aortic pulse wave velocity, a measure of vascular stiffness, and migraine, as reported in a recent study.
29 Nov 2019
Metformin Extended Release 500 mg,750 mg, and 1000 mg
01 Dec 2019
Pneumonia is a common infection– affecting around 3,200 people inSingapore in 2016 – making it the thirdmost common cause of hospitalisation inthe country. Its common complications,especially with delayed or inappropriatetreatment, include bacteraemia andseptic shock, lung abscesses, pleuraleffusions, empyema, pleurisy, respiratoryfailure and renal failure.

Dual combination of BP-lowering drugs trumps monotherapy as initial treatment for hypertension

11 Aug 2019

Treatment with low-to-standard dose dual combination therapy of blood pressure (BP)-lowering drugs is more effective than standard-dose monotherapy and does not increase withdrawals due to adverse events, a recent study has shown.

The investigators searched Medline, Embase and Central databases until August 2017 for double-blind randomized trials of dual combination therapy vs monotherapy in adults with hypertension who were either treatment naïve or untreated for at least 4 weeks. They classified regimens with reference to usual daily standard dose: for example, <1 + <1 for a combination of two drugs both a <1 standard-dose.

Random-effects models were used for the meta-analysis of 33 trials, which included a total of 13,095 participants with mean baseline BP of 155/100 mm Hg.

Dual combination of <1 + <1, 1 + <1, and 1 + 1 (ie, low-to-standard dose) vs standard-dose monotherapy demonstrated a dose–response relationship in reducing systolic BP (mean differences, 2.8 [95 percent CI, 1.6–4.0], 4.6 [3.4–5.7] and 7.5 [5.4–9.5] mm Hg, respectively) and in improving BP control (risk ratio [RR], 1.11 [0.92–1.34], 1.25 [1.16–1.35] and 1.42 [1.27–1.58], respectively).

Low-to-standard dose dual combinations also led to few withdrawals due to adverse events, showing no significant difference relative to those of standard-dose monotherapy (2.9 percent vs 2.2 percent; RR, 1.28, 0.85–1.92).

“There were fewer data for higher dose dual combinations, which did not appear to produce substantial additional efficacy and could potentially be less tolerable,” the investigators noted.

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Doctor - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
15 Feb 2020
A new noninvasive risk score―incorporating factors such as waist circumference, age, sex, and histories of hyperglycaemia and diabetes in the family― reliably identifies those at high dysglycaemia risk, reports a new Saudi Arabia study.
Yesterday
There appears to be no association between aortic pulse wave velocity, a measure of vascular stiffness, and migraine, as reported in a recent study.
29 Nov 2019
Metformin Extended Release 500 mg,750 mg, and 1000 mg
01 Dec 2019
Pneumonia is a common infection– affecting around 3,200 people inSingapore in 2016 – making it the thirdmost common cause of hospitalisation inthe country. Its common complications,especially with delayed or inappropriatetreatment, include bacteraemia andseptic shock, lung abscesses, pleuraleffusions, empyema, pleurisy, respiratoryfailure and renal failure.